About the Society
|
|
Contact Us
|
Site Map
General Public
Educational Resources
Clinical Trials Information
Gene and Cell Therapy Terminology
Gene & Cell Therapy Breakthroughs
FAQs
Gene and Cell Therapy Defined
Gene and Cell Therapy for Diseases
Sites of Interest
Media Resources
ASGCT News Releases
Gene and Cell Therapy in the News
Position Statements
Scientists & Clinicians
Job Bank
General Grant Information
ASGCT Grants and Awards
ASGCT Awards History
Information for Nominees/Candidates
Regulatory Affairs Information
Related Sites of Interest
Membership
New Members
Job Bank
New Investigator Center of Educational Resources (NICER)
NICER: Shared Resources
NICER: Funding Opportunities
NICER: FDA & RAC Guidance
NICER: Gene & Cell Therapy Centers
Members Login - Renew Today
My Profile
My History
Membership Directory
Renew My Dues
Change Username and Password
President's Message
Molecular Therapy
Newsletters
Become A Member
Types of Membership
Benefits
Join ASGCT
Meetings & Educational Programs
ASGCT Annual Meetings
2012 Annual Meeting
Future Annual Meetings
Archived Annual Meetings
ASGCT Workshops & Courses
NIH Gene Therapy Symposium
2011 Translational Science Training Course
Archived Workshops & Courses
NIH Gene Therapy Symposium
Get Involved
Suggest a New Investigator of the Month
Suggest Annual Meeting Speakers & Symposia
Volunteer to Serve on an ASGCT Committee
Volunteer to Review Annual Meeting Abstracts
Donate
Home
:
Meetings & Educational Programs
:
ASGCT Annual Meetings
Meetings & Educational Programs
ASGCT Annual Meetings
2012 Annual Meeting
Future Annual Meetings
Archived Annual Meetings
ASGCT Workshops & Courses
NIH Gene Therapy Symposium
12th Annual Meeting of the American Society of Gene Therapy
Presidential Symposium Evaluation
May 30, 2009
Presidential Symposium 430
2:30 pm – 5:00 pm
PRESENTATION RATINGS
Presenter/Topic
Overall Rating
Excellent
Good
Average
Poor
Very Poor
1. John Carpten, PhD
– Interrogation of Cancer Genomes: Towards More Profile-based Therapeutic Decision Making
2. John J. Nemunaitis, MD
– Personalized Cancer Gene Therapy
3. Helen E. Heslop, MD
– Immunotherapy of Viral Infections and Malignancy
4. Chiara Bonini, MD
– T-cell Based Gene Therapy to Improve Hematopoietic Stem Cell Transplantation
5. Rate the scientific level of the presentation
Too Basic
Appropriate
Too Advanced
6. Was the presentation fair, balanced and free from commercial bias?
Yes
No
If the answer to question 6 is no, please explain.
Other Comments and Suggestions: